Article Information
PubMed
Published By
Online ISSN
History
- Received November 22, 2021
- Revision received March 28, 2022
- Accepted March 30, 2022
- Published online April 22, 2022.
Copyright & Usage
© 2022 Nalbandian et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Minas Nalbandian1⇑,
- Mingming Zhao, Investigation, Methodology, Writing—review and editing1,
- Hiroki Kato, Conceptualization, Investigation, Methodology1,2,
- Tatsuya Jonouchi, Investigation, Methodology1,
- May Nakajima-Koyama, Investigation, Methodology3,
- Takuya Yamamoto, Resources, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing—review and editing3,4,5 and
- Hidetoshi Sakurai, Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—review and editing1⇑
- 1Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- 2Asahi Kasei Co., Ltd., Tokyo, Japan
- 3Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan
- 4Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
- 5Medical-risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan
- Correspondence: hsakurai{at}cira.kyoto-u.ac.jp
- mnalband@stanford.edu
Funding
AMED-The Core Center for iPS Cell Research
JP21bm0104001